Continuous Positive Airway Pressure (CPAP) Device Market Revenue Insights: Connected Health Drives USD 2.2-2.6 Bn Opportunity | Fact.MR

The global continuous positive airway pressure (CPAP) device market is expected to expand from approximately USD 5.09 billion in 2025 to around USD 7.41 billion by 2030, representing a compound annual growth rate (CAGR) of about 7.8% over the forecast period. Growth is being driven by rising prevalence of obstructive sleep apnea (OSA), increasing focus on home-based therapy, and advancements in CPAP device connectivity and comfort technologies.

CPAP devices deliver a continuous stream of pressurized air through a mask to keep the airways open during sleep, primarily treating OSA-a condition that significantly increases risks of cardiovascular disease, diabetes and mortality. As diagnosis rates improve, reimbursement policies evolve, and devices become more patient-friendly, the market for CPAP therapy is entering a phase of consistent growth.

Key Market Insights at a Glance

Market Value (2025): USD 5.09 billion

Forecast Value (2030): USD 7.41 billion

CAGR (2025-2030): ~7.8%

Leading Product Segment: CPAP machines (≈57% share in 2024)

Dominant End-User Segment: Home care settings (≈51% share in 2024)

Key Growth Regions: North America, followed by Asia-Pacific and Europe

Major Players: ResMed; Philips Respironics; Fisher & Paykel Healthcare; Drive DeVilbiss Healthcare; BMC Medical

To Access the Complete Data Tables & in-depth Insights, Request a Discount on this report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9331

Market Drivers / Growth Overview

Key factors propelling the CPAP device market include:

Surging prevalence of OSA and under-diagnosis: As awareness of sleep-disordered breathing disorders increases globally, more patients are being diagnosed and treated, boosting device demand.

Shift toward home-based therapeutic care: Home care models are gaining traction, accelerating CPAP adoption outside of clinic-bound settings and reducing total cost of care.

Technological innovation and patient comfort features: Device improvements such as auto-adjusting pressure, quieter motors, humidification, travel-friendly form factors and remote monitoring are enhancing adherence and device uptake.

Regulatory and reimbursement support: In key markets, favourable reimbursement and clinical guideline coverage for CPAP therapy bolster the market size.

Emerging-market expansion and infrastructure upgrade: The Asia-Pacific region, in particular, is witnessing increasing healthcare investment and improved diagnostic access, unlocking new device markets.

Persisting challenges for market participants include device non-compliance by patients, high equipment cost in some regions, and competition from alternative therapies (such as oral appliances) in mild OSA cases.

Segmentation & Key Drivers

By Product Type:

CPAP machines hold a dominant share, driven by demand for core therapy devices.

Consumables & accessories (masks, hoses, filters) are growing rapidly due to recurrent replacement cycles and higher patient comfort demand.

By End-User:

Home care settings account for the majority of device usage, supported by telehealth and direct-to-patient distribution.

Hospitals and sleep clinics continue to be important, particularly for diagnosis and initial therapy setup.

Segmentation growth is influenced by device-replacement frequencies, consumer comfort expectations, healthcare-reimbursement frameworks, and regional diagnostic penetration.

Regional & Country Insights

North America: The largest region owing to high diagnosis rates, advanced healthcare infrastructure, strong device-penetration and favourable reimbursement policies.

Europe: Steady growth supported by expanded sleep-clinic networks and increasing home-therapy adoption, although reimbursement and device-cost pressures vary by country.

Asia-Pacific: Forecasted to be the fastest-growing region, driven by rising disposable incomes, expanding healthcare access and growing awareness of sleep disorders in countries such as China and India.

Latin America / Middle East & Africa: Emerging opportunities exist as healthcare infrastructure matures and sleep-disorder awareness increases, though adoption remains lower compared to matured economies.

Competitive Landscape

The CPAP device market is moderately consolidated, with key players holding major shares and competing on differentiation, service, and geographic reach. Key companies include ResMed, Philips Respironics, Fisher & Paykel Healthcare, Drive DeVilbiss Healthcare and BMC Medical.

Competitive strategies include:

Launching new device models with enhanced connectivity, patient-data systems, and remote monitoring features.

Expanding distribution and service networks in emerging markets to capitalise on new patient-access opportunities.

Developing bundled therapy models (device + mask + monitoring platform) to improve adherence and reduce churn.

Collaborating with sleep-clinics, telehealth providers and payers to embed CPAP therapy within managed-care frameworks.

Market Outlook & Strategic Insights

Over the forecast period through 2030, the CPAP device market is positioned for robust growth as patient-care models evolve, adherence improves and devices become smarter and more user-friendly. Strategic imperatives for stakeholders include:

Prioritising home-based therapy and telemonitoring integration, which will drive both device and consumable demand.

Focusing on emerging markets, especially Asia-Pacific, where diagnosis rates are still low and growth potential remains high.

Investing in product innovation for comfort, portability and connectivity, as these features increasingly influence patient choice and reimbursement.

Building service and subscription models for consumables and remote-care platforms, to capture recurring revenue beyond device sales.

Monitoring regulatory developments, reimbursement shifts and guideline adoption, as these will strongly impact device demand and market access.

Companies that align with these strategic priorities-while managing cost, service infrastructure, and adherence outcomes-will be well-positioned to capture value in a market projected to reach approximately USD 7.41 billion by 2030.

➤Browse Full Report: https://www.factmr.com/report/continuous-positive-airway-pressure-device-market

➤Purchase Full Report for Detailed Insights

For access to full forecasts, regional breakouts, company share analysis, and emerging trend assessments, you can purchase the complete report: https://www.factmr.com/checkout/9331

Have specific requirements or need assistance on report pricing or have a limited budget? Please contact sales@factmr.com

➤Related Reports:

Continuous Cardiac Monitoring Systems Market: https://www.factmr.com/report/5265/continuous-cardiac-monitoring-systems-market

Mobile Continuous Patient Monitors Market: https://www.factmr.com/report/3348/mobile-continuous-patient-monitors-market

Seropositive Rheumatoid Arthritis Treatment Market: https://www.factmr.com/report/seropositive-rheumatoid-arthritis-treatment-market

IVF Devices Market: https://www.factmr.com/report/ivf-devices-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

➤About Fact.MR:

Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth.

This release was published on openPR.